ERBB4 and non-small cell lung carcinoma: What’s more, ERBB4 and TP53 deficiencies could moderate the infiltrating immune cells and augment tumor immunogenicity by activating the process of antigen presentation and anticancer cellular immunity in patients with NSCLC.